Stock Price
6.00
Daily Change
0.06 1.01%
Monthly
-2.76%
Yearly
34.83%
Q2 Forecast
5.76

Ardelyx reported $501.6M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Amgen USD 90.59B 445M Dec/2025
Ardelyx USD 501.6M 15.43M Dec/2025
aTyr Pharma USD 515.34M 408.68M Dec/2025
Corcept Therapeutics USD 836.65M 13.04M Dec/2025
Curis USD 19.97M 9.27M Dec/2025
Sanofi EUR 126.81B 25.48B Dec/2025
TG Therapeutics USD 1.06B 38.23M Dec/2025
United Therapeutics USD 7.88B 528.9M Dec/2025
Xoma USD 263.15M 39.7M Sep/2025